BackIQVIA Holdings Overview
IQVIA Holdings Inc

IQVIA Holdings Target Price

Where could IQV trade next? Consensus target price: $240.

Get informed when a big investor buys or sells

+ Follow

Share Price

$259.21

Average Target Price

$241.446.9% downside

9 analysts in the last 4 months

High: $287 | Low: $200

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-29RBC Capital$2474.7% downsideOpen
2026-07-29BMO CapitalSean Dodge$2704.2% upsideOpen
2026-07-29Robert W. BairdEric Coldwell$28710.7% upsideOpen
2026-07-13Mizuho SecuritiesAnn Hynes$23011.3% downsideOpen
2026-07-09Deutsche Bank$2407.4% downsideOpen
2026-07-06HSBCSidharth Sahoo$2407.4% downsideOpen
2026-07-01Robert W. Baird$2493.9% downsideOpen
2026-06-17Morgan StanleyKallum Titchmarsh$20022.8% downsideOpen
2026-06-03HSBC$21019% downsideOpen
2026-05-07Morgan Stanley$22513.2% downsideOpen
2026-04-08Evercore ISIElizabeth Anderson$18528.6% downsideOpen
2026-02-23Mizuho Securities$21517.1% downsideOpen
2026-02-19Truist Financial$2455.5% downsideOpen
2026-02-11Morgan Stanley$2407.4% downsideOpen
2026-02-06UBS$2407.4% downsideOpen
2026-02-06BMO Capital$2503.6% downsideOpen
2026-02-06Stifel Nicolaus$22015.1% downsideOpen
2026-02-06BarclaysLuke Sergott$21019% downsideOpen
2026-02-05Evercore ISIElizabeth Anderson$22513.2% downsideOpen
2026-01-09Mizuho Securities$2662.6% upsideOpen
2026-01-08UBSDan Leonard$2808% upsideOpen
2026-01-08Truist FinancialJailendra Singh$29011.9% upsideOpen
2025-12-15Barclays$23011.3% downsideOpen
2025-12-01Morgan Stanley$2652.2% upsideOpen
2025-10-29Stifel Nicolaus$2542% downsideOpen
2025-10-29UBSDan Leonard$2503.6% downsideOpen
2025-10-29Robert W. BairdEric Coldwell$2580.5% downsideOpen
2025-10-09HSBC$2359.3% downsideOpen
2025-10-08Evercore ISI$2407.4% downsideOpen
2025-10-02BarclaysLuke Sergott$20022.8% downsideOpen
2025-09-03Redburn PartnersJamie Clark$21417.4% downsideOpen
2025-07-25Mizuho SecuritiesAnn Hynes$22513.2% downsideOpen
2025-05-23Redburn PartnersJamie Clark$18827.5% downsideOpen
2025-05-15Mizuho SecuritiesAnn Hynes$19026.7% downsideOpen
2025-05-07BarclaysLuke Sergott$16536.3% downsideOpen
2025-04-25HSBCSidharth Sahoo$16038.3% downsideOpen
2024-11-04Truist FinancialJaliendra Singh$2652.2% upsideOpen
2024-10-31Evercore ISIElizabeth Anderson$2359.3% downsideOpen
2024-10-29RBC CapitalSean Dodge$2704.2% upsideOpen
2024-10-16Deutsche BankJustin Bowers$2704.2% upsideOpen
2024-10-14Redburn PartnersJamie Clark$2766.5% upsideOpen
2024-09-20Robert W. BairdEric Coldwell$2561.2% downsideOpen
2024-08-05Stifel NicolausJonathan Block$175.3832.3% downsideOpen
2024-07-23Truist FinancialJailendra Singh$30015.7% upsideOpen
2024-07-23Evercore ISIElizabeth Anderson$2704.2% upsideOpen
2024-07-23BarclaysLuke Sergott$2756.1% upsideOpen
2024-06-18Deutsche BankJustin Bowers$2756.1% upsideOpen
2024-06-13Robert W. BairdEric Coldwell$2417% downsideOpen
2024-06-06Goldman SachsMatthew Sykes$2704.2% upsideOpen
2022-08-02Evercore ISIElizabeth Anderson$2756.1% upsideOpen

IQVIA Holdings (IQV) FAQ

IQVIA Holdings (IQV) currently reports a target price of $240. Use the charts on this page to explore IQVIA Holdings's target price history and peer comparisons.

Analysts' average 12-month price target for IQVIA Holdings is $240, about 6.9% downside from the current share price of $259.21. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $240, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for IQVIA Holdings, and consider following IQV for alerts when major investors trade the stock.

IQVIA Holdings is classified in the Healthcare sector. On target price, it currently shows $240. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IQV with unrelated industries.